Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results
Protein Therapeutics by Immunoaffinity LC-MS: Latest Trends and...

Learn about the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics

High Throughput ADME Screening Services

Capabilities that accelerate preclinical studies

Q2 Solutions Oncology Infographic

Providing one global lab partner to support your oncology research from discovery to post-market

Central Laboratory Considerations for Deploying a Global Companion...

World CDx Europe 2018

Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Method for Normal-independent calculation of TMB

Building reliable germline variant estimates appropriate for use in calculating burden

Long-Term Disease-Free Survival in High Grade Serous Ovarian Cancer...

Application of RNA-based immune signatures in predicting disease-free survival

Effect of tumor purity on somatic mutation detection using next-generation...

Application of experiment and in silico approaches

Optimization of an RNA sequencing method for low quantity degraded samples

Optimizing the Illumina TruSeq® RNA Access method

Sensitive Detection of MET Exon 14 Skipping by RT-PCR and Next Generation...

RT-PCR assay that detects MET exon 14 skipping independent of the causal mutation

Tumor Mutational Burden: Guidelines for derivation and robustness of...

Explore our Tumor Mutational Burden (TMB) calculation methodology

STAR-SEQR: Accurate fusion detection and support for neoantigen...

The update of STAR-SEQR to report extended annotation in support of neoantigen research